+1 347 583 0215 (Text) info@uberevents.io

2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing

May 7-8, 2025 - Hyatt Regency New Brunswick, New Brunswick, NJ

REGISTER NOW             ATTENDEES LIST

2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing

May 7-8, 2025 - Hyatt Regency New Brunswick, New Brunswick, NJ

REGISTER NOW             ATTENDEES LIST

2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing

May 7-8, 2025 - Hyatt Regency New Brunswick, New Brunswick, NJ

REGISTER NOW             ATTENDEES LIST

Planing to attend? Save $700 on your ticket with super early-bird pricing ($800) + 3-for-the-price-of-2 group packs available. Offer ends in:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

The next generation of drug product development

and manufacturing technology is here…

Now in it’s 11th year, the popular 2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing returns this May.

Connect with 160+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.

2025’s Summit covers Controlled & Modified Drug Release, Drug Bioavailability Enhancement and Continuous Manufacturing technologies and capabilities. 

✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.

40+

Industry-led Speakers

160+

Senior Attendees

2

Tracked Streams

14+

Networking Hours

18

Solution Providers

Controlled and Modified Release

  • Oral Drug Delivery Systems
  • Long Acting Injectable Drug Delivery Systems
  • Transdermal Drug Delivery Systems
  • Modified release coating systems
  • Biodegradable and Biocompatible Polymers
  • Nanotechnology in Controlled Release
  • Pulmonary Drug Delivery Systems
  • The Role of Controlled Release in Optimizing Therapeutic Outcomes
  • Patient Centric / Pediatric Dose Development
  • 3D Printing in Controlled and Modified Release
  • Regulatory considerations
  • Continuous manufacturing of Controlled and Modified Release products
  • Continuous modified release coating systems
  • Continuous long-acting microsphere manufacturing

Bioavailability Enhancement

  • Formulation strategies for improved absorption of poorly soluble and/or poorly permeable drugs
    Solubility and dissolution enhancement techniques:
    – Lipid-Based formulations
    – Micronization
    – Nanomedicine
    – Nanocarriers
    – Spray Dried Dispersions (SDD)
    – Hot Melt Extrusion (HME)
    – Kinetisol
  • Biopharmaceutics classification system (BCS) and its implications
  • In vitro-in vivo correlations (IVIVCs)
  • Continuous manufacturing technologies for Bioavailability Enhancement

Continuous Manufacturing

  • Continuous biopharmaceutical manufacturing
  • Continuous manufacturing of oral solids
  • Spray Drying and Continuous Manufacturing of Pharmaceutical Materials
  • Melt Extrusion and Continuous Manufacturing of Pharmaceutical Materials
  • Continuous reactors for pharmaceutical manufacturing
  • Recent regulatory status in continuous manufacturing
  • Continuous Manufacturing equipment change over time
  • Capacity planning for continuous pharmaceutical manufacturing facilities
  • Continuous modified release coating equipment
  • Continuous fluid-bed coating
  • Continuous tablet-coating
  • Continuous lyophilization

2024 Speakers Included

Joe Della Rocca, PhD

Joe Della Rocca, PhD

Associate Principal Scientist

Merck

Anand Uhbe, PhD

Anand Uhbe, PhD

Senior Scientist (II), Sterile Liquids Product Development

Abbvie

Dipy Vasa, PhD

Dipy Vasa, PhD

Principal Scientist, Drug Product Dev

Pfizer

Ryan Pelis, PhD

Ryan Pelis, PhD

Sr. Principal Scientist, Pharmacokinetic Sciences

Novartis

Kellyn Zagaja, PhD

Kellyn Zagaja, PhD

Principal Scientist, Drug Product Design

Pfizer

Siddharth S. Kesharwani, PhD

Siddharth S. Kesharwani, PhD

Biopharmaceutics Scientist

Sanofi

Indrajit Ghosh, PhD

Indrajit Ghosh, PhD

Scientific Director, Biologics Product Development

Bristol Myers Squibb

Aruna Railkar, PhD

Aruna Railkar, PhD

Senior Research Fellow

Quotient Sciences

Seth Forster, PhD

Seth Forster, PhD

Associate Principal Scientist

Merck

Girish Nihalani, PhD

Girish Nihalani, PhD

Research Fellow, Product Development

Teva Pharmaceuticals

Liliana Miinea, PhD

Liliana Miinea, PhD

Global Technology Manager, Pharmaceutical Excipients

Lubrizol

Kelly Zhang, PhD

Kelly Zhang, PhD

Senior Scientist, Analytical Enabling Capabilities – MBC | Analytical Research & Development

Merck

Misha Murashov, PhD

Misha Murashov, PhD

Assoc Prin. Scientist, Sterile & Specialty Products BDB

Merck

Prajwal Thool

Prajwal Thool

Scientist III, Drug Product Development

Genentech

Zafar Iqbal, PhD

Zafar Iqbal, PhD

Vice President & Head of Pharmaceutical Development

Glatt Group

Jim Baxter

Jim Baxter

NA Technical Business Development Manager

Lubrizol Life Science

Firouz Asgarzadeh, PhD

Firouz Asgarzadeh, PhD

President of Consulting Services

OSD Pharmaceutical Solutions

Vivek Gupta, PhD

Vivek Gupta, PhD

Associate Professor, Pharmaceutical Sciences

St. John’s University

Erica Schlesinger, PhD

Erica Schlesinger, PhD

Vice President of Technical Development

Seran Biosciences

Ketan Patel, PhD

Ketan Patel, PhD

Associate Professor of Pharmaceutics

St. John’s University

Previous Sponsors & Exhibitors

Gattefosse
Gattefosse
Gattefosse
Gattefosse
Gattefosse
Gattefosse
Gattefosse
Absorption Systems
Gattefosse
Gattefosse
Adare Pharma Solutions
Gattefosse
Fluid Air
Gattefosse
Gattefosse
Gattefosse

Download The Controlled Release Previous Attendee List

Partnering with the 2025 Summit will also help you:

  • Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
  • Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
  • Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
  • Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions

"*" indicates required fields

Registration Pricing:

Super Early-Bird

Register Before December 17, 2024

Regular Attendance

$800

3-for-2 Group Pack

$1600

On-Demand

$595

Early-Bird Rate

Register Before Jan 31, 2025

Regular Attendance

$1100

3-for-2 Group Pack

$2200

On-Demand

$595

ONSITE PRICING

Register March 22, 2025 Onwards

Regular Attendance

$1600

3-for-2 Group Pack

$3200

On-Demand

$795

Registration